NCT00864240View on ClinicalTrials.gov

"The Dose-response Pilot Study of Topically Delivered Clobetasol Propionate Lotion in Healthy Adult Subjects"

PHASE1CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

October 31, 2005

Study Completion Date

October 31, 2005

Conditions
Healthy
Interventions
DRUG

Clobex TM (Clobetasol) 0.05% Lotion, single exposure

Subjects received Galderma Laboratories, L.P. formulated products

Trial Locations (1)

77042-4712

Novum Pharmaceutical Research Services, Houston

Sponsors

Lead Sponsor

Actavis Inc.
All Listed Sponsors
lead

Actavis Inc.

INDUSTRY